Generics

Thorazine had a market value of approximately $120 million for the 12 months ended November 2020, according to IQVIA, although actual generic market values are expected to be lower.

Ephedrine sulfate injection had a market value of approximately $64 million in the 12 months ended November 2020, according to IQVIA.

The Sabril brand and generic had a market value of approximately $141 million for the most recent 12 months ending in December 2020, according to IQVIA.

Unichem's generic Celebrex will be available in four dosage strengths: 50 mg, 100 mg, 200 mg, and 400 mg.

Sandoz has signed a U.S. commercialization deal with Slayback Pharma to launch generic Firazyr (icatibant injection).

Drug Store News reached out to a number of key industry executives to get their sense of how the pharmacy industry managed in 2020.

Prazosin capsules had a market value of approximately $46.2 million, according to IQVIA.

Evekeo tablets had a market value of approximately $21.5 million for the 12-month period ended November 2020, according to IQVIA.